Ovarian Conservation at the Time of Hysterectomy
With hysterectomy representing a common opportunity for removal of the ovaries, a general approach to conservation or removal should focus on risk stratification. Placing aside known pathology of the ovary at the time of hysterectomy, the removal of otherwise normal appearing ovaries is a balance of acute surgical risks and long-term health implications with ovarian removal versus retention. An individualized discussion with patients regarding the risks and benefits of ovarian removal versus conservation should occur with patients prior to hysterectomy.
The baseline lifetime risk for ovarian cancer is 1.4% in the general population. Elective bilateral oophorectomy will significantly reduce, though not entirely eliminate, ovarian cancer risk. Oophorectomy will also reduce the risk of breast cancer when performed in premenopausal women. Patients with known hereditary genetic abnormalities such as BRCA 1/2 or Lynch syndrome should consider ovarian removal as dictated by current guidelines, taking care to include further dissection of the ovarian vessels or consult additional expertise with a gynecologic oncologist. Women with a strong family history of gynecologic, colon, and/or breast cancers should be screened to see if they qualify for genetic testing. If an obstetrician–gynecologist does not have the necessary knowledge or expertise to counsel a patient appropriately, referral to a genetic counselor should be considered. Protective effects to reduce ovarian cancer risk include oral contraceptive use, breastfeeding, and previous tubal ligation or salpingectomy. It is unclear if removal of a single ovary changes overall ovarian cancer risk and is not routinely performed for this indication. When ovaries are retained, re-operation in the future for ovarian malignancy is rare, and ovarian operation for any indication in the future appears to be less than 10%.
Elective ovarian removal at hysterectomy also involves short and long-term risks. An ovarian remnant will occur following 3-4% of cases. Unlike salpingectomy alone, ovarian removal does generally confer a small added operative complication risk. Additional surgical time in the operating room with oophorectomy is largely dependent on existing pathology and highly variable. In women less than age 50, elective ovarian removal is associated with increased rates of all-cause mortality, and there are theoretical risks for increased mortality with removal through age 65. This mortality risk appears to be largely mitigated with estrogen therapy through the average age of menopause. Additional risks associated with bilateral oophorectomy include increased rates of cardiovascular disease, osteoporosis, glaucoma, acute vasomotor symptoms, and sexual dysfunction with higher rates associated with earlier age of removal. While risks and benefits must be weighed for each individual case, current trends lean towards ovarian conservation in the setting of otherwise normal appearing ovaries at the time of hysterectomy through age 65.
Parker WH, Feskanich D, Broder MS, et al. Long-term mortality associated with oophorectomy compared with ovarian conservation in the nurses' health study. Obstet Gynecol. 2013 Apr;121(4):709-16. doi: 10.1097/AOG.0b013e3182864350.
Mytton J, Evison F, Chilton PJ, Lilford RJ. Removal of all ovarian tissue versus conserving ovarian tissue at time of hysterectomy in premenopausal patients with benign disease: study using routine data and data linkage. BMJ. 2017 Feb 6;356:j372. doi: 10.1136/bmj.j372.
Initial Approval: July 2019
********** Notice Regarding Use ************
The Foundation for Exxcellence in Women’s Health, Inc (“Foundation”) is committed to accuracy and will review and validate all Pearls on an ongoing basis to reflect current practice.
This document is designed to aid practitioners in providing appropriate obstetric and gynecologic care. Recommendations are derived from major society guidelines and high quality evidence when available, supplemented by the opinion of the author and editorial board when necessary. It should not be construed as dictating an exclusive course of treatment or procedure to be followed.
Variations in practice may be warranted when, in the reasonable judgment of the treating clinician, such course of action is indicated by the condition of the patient, limitations of available resources, or advances in knowledge or technology. The Foundation reviews the articles regularly; however, its publications may not reflect the most recent evidence. While we make every effort to present accurate and reliable information, this publication is provided “as is” without any warranty of accuracy, reliability, or otherwise, either express or implied. The Foundation does not guarantee, warrant, or endorse the products or services of any firm, organization, or person. Neither the Foundation, SASGOG nor their respective officers, directors, members, employees, or agents will be liable for any loss, damage, or claim with respect to any liabilities, including direct, special, indirect, or consequential damages, incurred in connection with this publication or reliance on the information presented.
© Copyright 2019 - The Foundation for Exxcellence in Women's Health, Inc. All rights reserved. No publication, reuse or dissemination allowed without written permission.Back to Search Results